We are pleased to welcome @Lara Zibners, MD as an Advisor to Cern.

Dr. Zibners is Co-Founder and Chairman of Calla Lily Clinical Care and a long-time advocate for innovation in women’s health. As a physician and entrepreneur operating across the U.S. and Europe, she brings a global lens to commercialization strategy and platform growth.

The women’s health medical device ecosystem is collaborative and interconnected. Over the past several years, our leadership teams have shared insights on what it truly takes to build companies from the ground up and bring meaningful technologies to market.

We look forward to working together as Cern advances its light-based, non-hormonal women’s health platform.

More News

08 August 24

awaards

OctaneOC Cern Best of Medtech 2024

Cern Corporation has been selected as a finalist for OctaneOC’s prestigious “Best Innovation in Medtech / Device” category ✨ Tech Innovators,...

18 October 25

Clinical Trials Vanguard Interview with Dr. Santos

Cern Corporation is featured in Clinical Trial Vanguard, where our Chief Medical Officer, Dr. Melanie Santos, discusses our Cern Device, a...

17 September 24

Our Chief Medical Officer, Dr. Melanie Santos just completed an interview with Femtech Health Podcast

The newest episode of the Femtech Health Podcast is live! Listen to the episode here In this episode, we’re joined by...